4.6 Review

Classical and noncanonical functions of miRNAs in cancers

Journal

TRENDS IN GENETICS
Volume 38, Issue 4, Pages 379-394

Publisher

CELL PRESS
DOI: 10.1016/j.tig.2021.10.002

Keywords

-

Funding

  1. Charite -Universitatsmedizin Berlin
  2. Berlin Institute of Health
  3. Northern Norway Regional Health Authority [HNF1585-21]
  4. National Institutes of Health (NIH/NCATS) through the NIH Common Fund, Office of Strategic Coordination (OSC) [UH3TR00943]
  5. NCI [1R01 CA182905-01, 1R01CA222007-01A1]
  6. NIGMS [1R01GM122775-01]
  7. Department of Defense [CA160445P1]
  8. Chronic Lymphocytic Leukemia Moonshot Flagship project
  9. CLL Global Research Foundation 2019 grant
  10. CLL Global Research Foundation 2020 grant
  11. Estate of C.G. Johnson, Jr.

Ask authors/readers for more resources

This article summarizes the important role of miRNAs in cancer, with a particular focus on the less studied mechanisms of regulation in cancer.
Alterations in microRNAs (miRNAs) expression are causative in the initiation and progression of human cancers. The molecular events responsible for the wide-spread differential expression of miRNAs in malignancy are exemplified by their location in cancer-associated genomic regions, epigenetic mechanisms, transcrip-tional dysregulation, chemical modifications and editing, and alterations in miRNA biogenesis proteins. The classical miRNA function is synonymous with post-transcriptional repression of target protein genes. However, several studies have reported miRNAs functioning outside this paradigm and some of these novel modes of regulation of gene expression have been implicated in cancers. Here, we summarize key aspects of miRNA involvement in cancer, with a special focus on these lesser-studied mechanisms of action.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

TNF-alpha releasing capacity of the whole blood drops after open total splenectomy, but increases after partial/subtotal or minimally invasive splenectomy

Mihnea P. Dragomir, Stefan Tudor, Monica Lacatus, Oana Stanciulea, Bogdan Trandafir, Adriana Diaconu, Daniel Coriu, Anca Colita, Gabriela Droc, Raluca Purnichescu-Purtan, George Calin, Catalin Vasilescu

Summary: The study found that after splenectomy, the releasing capacity of TNF-alpha in whole blood significantly decreased, while the capacities of IL-6 and IL-10 did not show significant changes. The impact of total splenectomy (TS) and subtotal/partial splenectomy (S/PS) on cytokine releasing capacities differed, with open surgery leading to a decrease in TNF-alpha releasing capacity and minimally invasive surgery significantly increasing it.

ACTA CHIRURGICA BELGICA (2022)

Article Medicine, Research & Experimental

Construction and validation of prognostic nomogram for metaplastic breast cancer

Yongfeng Li, Daobao Chen, Haojun Xuan, Mihnea P. Dragomir, George A. Calin, Xuli Meng, Meng Chen, Hongchuan Jin

Summary: This study aimed to develop nomogram models for predicting overall survival and cancer-specific survival of patients with metaplastic breast carcinoma (MBC). The study collected data from 1973 to 2015 and used Cox analyses and calibration plots to evaluate model performance. The results showed that the nomogram models had good accuracy in predicting patient survival.

BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2022)

Article Oncology

Clinical and Dosimetric Predictors for Postoperative Cardiopulmonary Complications in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy and Surgery

Zhaohui Liang, Kongjia Luo, Yuting Wang, Qiuli Zeng, Xiuzhen Ling, Sifen Wang, Mihnea P. Dragomir, Qiaoqiao Li, Hong Yang, Mian Xi, Baoqing Chen

Summary: This study investigated the correlations between clinical factors and dose-volume histogram (DVH) parameters with postoperative cardiopulmonary complications in locally advanced esophageal squamous cell carcinoma (ESCC) patients. A nomogram model was constructed to predict the risk of these complications. The results showed that male sex, post-RT forced expiratory volume in 1 s (FEV1), mean lung dose (MLD), and pre-RT monocyte were significant predictors of postoperative pulmonary complications. Additionally, the paclitaxel and cisplatin (TP) concurrent chemotherapy regimen was an independent predictor of cardiac complications.

ANNALS OF SURGICAL ONCOLOGY (2023)

Editorial Material Oncology

ASO Author Reflections: The Prophets of Postoperative Cardiopulmonary Complications in Esophageal Squamous Cell Carcinoma Patients Receiving Trimodality Therapy

Zhaohui Liang, Mihnea P. Dragomir, Mian Xi, Baoqing Chen

ANNALS OF SURGICAL ONCOLOGY (2023)

Editorial Material Oncology

ASO Visual Abstract: Clinical and Dosimetric Predictors for Postoperative Cardiopulmonary Complications in Patients with Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy and Surgery

Zhaohui Liang, Kongjia Luo, Yuting Wang, Qiuli Zeng, Xiuzhen Ling, Sifen Wang, Mihnea P. Dragomir, Qiaoqiao Li, Hong Yang, Mian Xi, Baoqing Chen

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Biochemistry & Molecular Biology

The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma

Florian N. N. Loch, Carsten Kamphues, Katharina Beyer, Christian Schineis, Wael Rayya, Johannes C. C. Lauscher, David Horst, Mihnea P. P. Dragomir, Simon Schallenberg

Summary: Immune checkpoint therapy has shown promise in treating solid tumors, but its role in pancreatic ductal adenocarcinoma is limited. This study aimed to create a profile of immune checkpoint expression and its prognostic relevance in PDAC. The presence of VISTA and PD-L1 significantly correlated with shorter overall survival, suggesting they may be potential targets for ICT.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Multidisciplinary Sciences

17 beta-estradiol promotes extracellular vesicle release and selective miRNA loading in ERa-positive breast cancer

Rares Drula, Barbara Pardini, Xiao Fu, Mireia Cruz De los Santos, Ancuta Jurj, Lan Pang, Sherien M. El-Daly, Linda Fabris, Erik Knutsen, Mihnea P. Dragomir, Recep Bayraktar, Yongfeng Li, Meng Chen, Filippo Del Vecchio, Lea Berland, Jessica Dae, Daniel Fan, Masayoshi Shimizu, Anh M. Tran, Mercedes Barzi, Carlotta Pioppini, Angelica M. Gutierrez, Cristina Ivan, Salyna Meas, Carolyn S. Hall, Suresh K. Alahari, Ioana Berindan-Neagoe, Muller Fabbri, Anthony Lucci, Banu Arun, Simone Anfossi, George A. Calin

Summary: The causes and consequences of abnormal biogenesis of extracellular vesicles (EVs) in breast cancers (BCs), especially estrogen receptor-positive (ER+) BCs, have been investigated. It was found that physiological doses of estrogen can promote EV secretion from ER+ BC cells by inhibiting miR-149-5p, which affects the regulatory activity of SP1 on the EV biogenesis factor nSMase2. In addition, the downregulation of miR-149-5p promotes the expression of hnRNPA1, responsible for loading let-7's miRNAs into EVs. This estrogen-driven mechanism leads to the elimination of tumor suppressor miRNAs in EVs, affecting tumor-associated macrophages in the microenvironment.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Article Pathology

LRP1B-a prognostic marker in tubo-ovarian high-grade serous carcinoma

Svenja Kolb, Inga Hoffmann, Nanna Monje, Mihnea P. Dragomir, Paul Jank, Philip Bischoff, Carlotta Keunecke, Jonathan Pohl, Catarina Alisa Kunze, Sofya Marchenko, Wolfgang D. Schmitt, Hagen Kulbe, Christine Sers, Jalid Sehouli, Elena Ioana Braicu, Carsten Denkert, Silvia Darb-Esfahani, David Horst, Bruno V. Sinn, Eliane T. Taube

Summary: This study highlights the significant prognostic role of the LRP1B protein in tubo-ovarian high-grade serous carcinoma, showing that its high expression is associated with prolonged overall survival and progression-free survival in patients.

HUMAN PATHOLOGY (2023)

Article Medicine, General & Internal

DNA methylation-based classifier differentiates intrahepatic pancreato-biliary tumours

Mihnea P. Dragomir, Teodor G. Calina, Eilis Perez, Simon Schallenberg, Meng Chen, Thomas Albrecht, Ines Koch, Peggy Wolkenstein, Benjamin Goeppert, Stephanie Roessler, George A. Calin, Christine Sers, David Horst, Florian Rossner, David Capper

Summary: This study developed a classifier that can differentiate between iCCAs, intrahepatic metastases of a PAAD, and normal bile duct tissue with high accuracy, which can improve the diagnosis of pancreato-biliary cancers of the liver.

EBIOMEDICINE (2023)

Article Medicine, Research & Experimental

Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response

Mihnea P. Dragomir, Enrique Fuentes-Mattei, Melanie Winkle, Keishi Okubo, Recep Bayraktar, Erik Knutsen, Aiham Qdaisat, Meng Chen, Yongfeng Li, Masayoshi Shimizu, Lan Pang, Kevin Liu, Xiuping Liu, Simone Anfossi, Huanyu Zhang, Ines Koch, Anh M. Tran, Swati Mohapatra, Anh Ton, Mecit Kaplan, Matthew W. Anderson, Spencer J. Rothfuss, Robert Silasi, Ravi S. Keshari, Manuela Ferracin, Cristina Ivan, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein, Constantin Georgescu, Pinaki P. Banerjee, Rafet Basar, Ziyi Li, David Horst, Catalin Vasilescu, Maria Teresa S. Bertilaccio, Katayoun Rezvani, Florea Lupu, Sai-Ching Yeung, George A. Calin

Summary: miR-93-5p plays a critical role in sepsis pathogenesis and inhibiting it can prolong the survival of mice with sepsis induced by abdominal infection.

JOURNAL OF CLINICAL INVESTIGATION (2023)

Article Biochemistry & Molecular Biology

Blood Transcriptome Analysis of Septic Patients Reveals a Long Non-Coding Alu-RNA in the Complement C5a Receptor 1 Gene

Ase Emblem, Erik Knutsen, Tor Erik Jorgensen, Hilde Fure, Steinar Daae Johansen, Ole-Lars Brekke, Tom Eirik Mollnes, Bard Ove Karlsen

Summary: Understanding the expression of long non-coding RNAs containing Alu elements in inflammation is crucial for predicting the development of severe diseases. By using a computational approach, we identified 48 immune genes with Alu insertion as potential candidates for further study, and one of these candidates located within the C5aR1 gene holds promise as a target for RNA therapeutics.

NON-CODING RNA (2022)

Meeting Abstract Biochemistry & Molecular Biology

Bulk and single-cell RNA-seq analysis of complement and coagulation cascades in severe inflammation: The whole blood model versus patient data

Ase Emblem, Arne Martin Slatsve, Erik Knutsen, Robin Mjelle, Corinna Lau, Anne Landsem, Per Nilsson, Ole-Lars Brekke, Tom Eirik Mollnes, Bard Karlsen

MOLECULAR IMMUNOLOGY (2022)

Review Biochemistry & Molecular Biology

Targeting non-coding RNAs to overcome cancer therapy resistance

BaoQing Chen, Mihnea P. Dragomir, Chen Yang, Qiaoqiao Li, David Horst, George A. Calin

Summary: Non-coding RNAs (ncRNAs), especially microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), play a crucial role in regulating resistance to different cancer therapies by rewiring essential signaling pathways. ncRNAs have the potential to serve as biomarkers for predicting and detecting resistance to treatment, and targeting ncRNAs may be a strategy to overcome cancer treatment resistance.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

No Data Available